Suppr超能文献

ADAM10 对于 SCF 诱导的肥大细胞迁移是必需的。

ADAM10 is required for SCF-induced mast cell migration.

机构信息

Department of Biology, Virginia Commonwealth University (VCU), Richmond, VA 23284-2012, United States.

Department of Microbiology and Immunology, Virginia Commonwealth University (VCU), Richmond, VA 23284-2012, United States.

出版信息

Cell Immunol. 2014 Jul;290(1):80-8. doi: 10.1016/j.cellimm.2014.05.005. Epub 2014 May 21.

Abstract

A Disintegrin and Metalloproteinase (ADAM)-10 plays critical roles in neuronal migration and distribution. Recently, ADAM10 deletion was shown to disrupt myelopoiesis. We found that inducible deletion of ADAM10 using Mx1-driven Cre recombinase for a period of three weeks resulted in mast cell hyperplasia in the skin, intestine and spleen. Mast cells express surface ADAM10 in vitro and in vivo, at high levels compared to other immune cells tested. ADAM10 is important for mast cell migration, since ADAM10-deficiency reduced c-Kit-mediated migration. As with some mast cell proteases, ADAM10 expression could be altered by the cytokine microenvironment, being inhibited by IL-10 or TGFβ1, but not by several other T cell-derived cytokines. Collectively these data show that the ADAM10 protease is an important factor in mast cell migration and tissue distribution, and can be manipulated by environmental cues.

摘要

一种解整合素金属蛋白酶(ADAM)-10 在神经元迁移和分布中发挥着关键作用。最近的研究表明,ADAM10 的缺失会破坏髓系细胞的生成。我们发现,使用 Mx1 驱动的 Cre 重组酶诱导 ADAM10 缺失 3 周,会导致皮肤、肠道和脾脏中的肥大细胞增生。肥大细胞在体外和体内表达高水平的表面 ADAM10,与其他测试的免疫细胞相比。ADAM10 对肥大细胞迁移很重要,因为 ADAM10 缺失会减少 c-Kit 介导的迁移。与一些肥大细胞蛋白酶一样,ADAM10 的表达可以被细胞因子微环境改变,被 IL-10 或 TGFβ1 抑制,但不受其他几种 T 细胞衍生细胞因子的影响。总的来说,这些数据表明 ADAM10 蛋白酶是肥大细胞迁移和组织分布的一个重要因素,并且可以通过环境线索进行操纵。

相似文献

1
ADAM10 is required for SCF-induced mast cell migration.
Cell Immunol. 2014 Jul;290(1):80-8. doi: 10.1016/j.cellimm.2014.05.005. Epub 2014 May 21.
3
Knockdown of ADAM10 inhibits migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis.
Mol Med Rep. 2015 Oct;12(4):5517-23. doi: 10.3892/mmr.2015.4011. Epub 2015 Jul 1.
4
ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch.
J Immunol. 2011 Apr 1;186(7):4244-52. doi: 10.4049/jimmunol.1003318. Epub 2011 Mar 2.
5
Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Oncol Rep. 2014 Nov;32(5):1913-22. doi: 10.3892/or.2014.3418. Epub 2014 Aug 19.
6
ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
Circ Res. 2008 May 23;102(10):1192-201. doi: 10.1161/CIRCRESAHA.107.169805. Epub 2008 Apr 17.
7
ADAM10 regulates Notch function in intestinal stem cells of mice.
Gastroenterology. 2014 Oct;147(4):822-834.e13. doi: 10.1053/j.gastro.2014.07.003. Epub 2014 Jul 16.
8
Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
PLoS One. 2013 Oct 9;8(10):e76853. doi: 10.1371/journal.pone.0076853. eCollection 2013.
9
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
J Invest Dermatol. 2010 Mar;130(3):763-73. doi: 10.1038/jid.2009.335. Epub 2009 Oct 29.
10
Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.
Int J Mol Med. 2010 Aug;26(2):281-8. doi: 10.3892/ijmm_00000463.

引用本文的文献

1
ADAM10: Possible functions in enamel development.
Front Physiol. 2022 Nov 25;13:1032383. doi: 10.3389/fphys.2022.1032383. eCollection 2022.
2
Tetraspanins in the regulation of mast cell function.
Med Microbiol Immunol. 2020 Aug;209(4):531-543. doi: 10.1007/s00430-020-00679-x. Epub 2020 Jun 7.
3
Mast Cells in Liver Fibrogenesis.
Cells. 2019 Nov 13;8(11):1429. doi: 10.3390/cells8111429.
4
SCF promotes the production of IL-13 via the MEK-ERK-CREB signaling pathway in mast cells.
Exp Ther Med. 2019 Oct;18(4):2491-2496. doi: 10.3892/etm.2019.7866. Epub 2019 Aug 8.
5
Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention.
Front Immunol. 2019 Mar 28;10:580. doi: 10.3389/fimmu.2019.00580. eCollection 2019.
8
Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.
Mediators Inflamm. 2017;2017:9621724. doi: 10.1155/2017/9621724. Epub 2017 Feb 5.
9
ADAM Proteases and Gastrointestinal Function.
Annu Rev Physiol. 2016;78:243-76. doi: 10.1146/annurev-physiol-021014-071720. Epub 2015 Nov 19.

本文引用的文献

1
Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway.
J Immunol. 2013 Nov 1;191(9):4505-13. doi: 10.4049/jimmunol.1202723. Epub 2013 Sep 25.
3
Mast cell chemotaxis - chemoattractants and signaling pathways.
Front Immunol. 2012 May 25;3:119. doi: 10.3389/fimmu.2012.00119. eCollection 2012.
4
Dual functions of cell-autonomous and non-cell-autonomous ADAM10 activity in granulopoiesis.
Blood. 2011 Dec 22;118(26):6939-42. doi: 10.1182/blood-2011-06-357210. Epub 2011 Oct 31.
5
A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture.
J Immunol. 2011 Nov 15;187(10):5114-22. doi: 10.4049/jimmunol.1102172. Epub 2011 Oct 12.
6
Mast cell proteases as protective and inflammatory mediators.
Adv Exp Med Biol. 2011;716:212-34. doi: 10.1007/978-1-4419-9533-9_12.
7
A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma.
Allergy. 2011 Sep;66(9):1193-200. doi: 10.1111/j.1398-9995.2011.02614.x. Epub 2011 May 10.
9
ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch.
J Immunol. 2011 Apr 1;186(7):4244-52. doi: 10.4049/jimmunol.1003318. Epub 2011 Mar 2.
10
Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.
J Biol Chem. 2011 Apr 8;286(14):12042-8. doi: 10.1074/jbc.M110.138966. Epub 2011 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验